A new treatment for cancer that uses artificial immune cells to trigger the body to kill cancerous cells will raise a series A round this spring and look to an investigational new drug (IND) application next year.NexImmune is an early stage biopharmaceutical company engineering artificial cells that can stimulate the immune system to treat cancer, [...]

An Oklahoma pharmaceutical skin care company thinks it has set itself apart in the crowded dermatology market with a line of safe, natural topical therapeutics for various inflammatory skin conditions that it plans on taking to a national market this year.DermaMedics LLC’s products contain a phytochemical called Therosol, which has natural anti-inflammatory and antiaging properties, [...]

Among the three most common types of prostate cancer treatment, external beam radiation therapy is the most toxic and costly, according to a Cleveland Clinic researcher.Dr. Jay Ciezki and colleagues analyzed the Medicare records of more than 137,000 men who received one of three prostate cancer treatments — external beam radiation therapy; prostatectomy, or removal [...]

A newly formed University of Illinois spinoff company could be on to something good with a new drug treatment for cancer that targets an enzyme commonly found in various tumor types.Department of Chemistry professor Paul Hergenrother and a handful of other co-founders of Vanquish Oncology are developing compounds that selectively kill cancer cells by targeting [...]

Immunome, which has developed a way to clone monoclonal human antibodies that can be used to help develop more effective cancer drugs and with potential applications for rare diseases, has signed its first research and development partnership with a Big Pharma company.The Wynnewood, Pennsylvania company’s approach differs from its competitors, says Timothy Pelura, the CEO. [...]

An Atlanta, Georgia company developing surgical imaging technology for image-guided cancer surgery is looking to add $6 million in anticipation of its European product launch.Spectropath Inc.’s technology is a disposable, handheld, pen-like device used with an agent to make cancerous tissue turn a fluorescent color during tumor removal surgery, said President and CEO Ralph Gaskins [...]

As drug partnering auditions go, Pozen (NASDAQ:POZN) has played this role before: The small drug developer flirts with a large pharmaceutical company who has the resources and the reach to take its promising drug candidate global.Many companies audition without so much as a callback from Big Pharma. Chapel Hill, North Carolina-based Pozen has already come [...]

GlaxoSmithKline (NYSE:GSK) is not giving up finding a role for enlarged prostate drug Avodart as a prostate cancer treatment.A study published today in The Lancet suggests that Avodart, also called dutasteride, could slow prostate cancer’s progression in men who have low-risk prostate cancer under active surveillance. But an editorial also published today in The Lancet [...]

The former chairman of BNP Sunstone and a pharmaceutical veteran has joined the board of a firm developing a cancer vaccine.Martyn Greenacre has served as a CEO of Delsys Pharmaceutical Corp., a formulation and drug-delivery system company later acquired by Elan. He worked in the European division of SmithKline Beecham in several roles that included [...]

Julie Grabow, an oncologist at the Fred Hutchinson Cancer Center in Seattle, recently prescribed an exciting new therapy for a 60-year-old woman with metastatic breast cancer. Three-and-a-half years into her battle against the disease, the patient had already exhausted three different anti-estrogen therapies, each of which only put a temporary check on the spreading tumors.The [...]